292 related articles for article (PubMed ID: 35130884)
1. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection.
Cheng YW; Chuang YC; Huang SW; Liu CC; Wang JR
J Biomed Sci; 2022 Feb; 29(1):10. PubMed ID: 35130884
[TBL] [Abstract][Full Text] [Related]
2. Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.
Lee YP; Yu CK; Wong TW; Chen LC; Huang BM
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543718
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).
Abd-Aziz N; Lee MF; Ong SK; Poh CL
Virology; 2024 Jan; 589():109941. PubMed ID: 37984152
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
Wei Y; Liu H; Hu D; He Q; Yao C; Li H; Hu K; Wang J
Lab Invest; 2024 Feb; 104(2):100298. PubMed ID: 38008182
[TBL] [Abstract][Full Text] [Related]
5. Antivirals and vaccines for Enterovirus A71.
Lin JY; Kung YA; Shih SR
J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.
Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH
Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333
[TBL] [Abstract][Full Text] [Related]
7. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication.
Lin D; Dong X; Xiao X; Xiang Z; Lei X; Wang J
Antiviral Res; 2023 Dec; 220():105761. PubMed ID: 37992763
[TBL] [Abstract][Full Text] [Related]
9. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
11. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
12. Rock1 is a novel host dependency factor of human enterovirus A71: Implication as a drug target.
Zhao X; Li C; Chiu MC; Qiao R; Jiang S; Wang P; Zhou J
J Med Virol; 2022 Nov; 94(11):5415-5424. PubMed ID: 35791459
[TBL] [Abstract][Full Text] [Related]
13. Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication.
Yajie H; Shenglan W; Wei Z; Rufang L; Tingting Y; Yunhui Z; Jie S
Virus Res; 2023 Jun; 330():199118. PubMed ID: 37072100
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis.
Tee HK; Zainol MI; Sam IC; Chan YF
Expert Rev Anti Infect Ther; 2021 Jun; 19(6):733-747. PubMed ID: 33183118
[No Abstract] [Full Text] [Related]
15. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening of ROCK1 inhibitors for the discovery of Enterovirus-A71 antivirals.
Qiao R; Tang W; Li J; Li C; Zhao C; Wang X; Li M; Cui Y; Chen Y; Cai G; Wu Q; Zhao X; Wang P
Virology; 2023 Aug; 585():205-214. PubMed ID: 37384967
[TBL] [Abstract][Full Text] [Related]
17. Isolation and Characterization of scFv Antibody against Internal Ribosomal Entry Site of Enterovirus A71.
Hlaing ST; Srimanote P; Tongtawe P; Khantisitthiporn O; Glab-Ampai K; Chulanetra M; Thanongsaksrikul J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373012
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
[TBL] [Abstract][Full Text] [Related]
19. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3D
Tan C; Qin X; Tan Y; Dong X; Chen D; Liang L; Li J; Niu R; Cao K; He Z; Wei G; Huang M; Zhu X
J Med Virol; 2023 Aug; 95(8):e29030. PubMed ID: 37565734
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.
Ibba R; Carta A; Madeddu S; Caria P; Serreli G; Piras S; Sestito S; Loddo R; Sanna G
Viruses; 2021 Jan; 13(1):. PubMed ID: 33406781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
